Newbie from life sciences (chemist) transitioning over to Big 4 Deloitte in Governance, regulatory, & risk strategies

newbie here!

Hello everyone, I love reading WSO, a lot of helpful postings on big 4 consulting; but, I wasn't able to find topics on life sciences/healthcare for someone w/ a science degree coming from the industry.

I am a chemist w/ 4.5 yrs of clinical experience (worked at a CRO, clinical research firm for 3 yrs and 1.5 at a Medical Academia Center) and hold an BS & MS in Drug Regulations (pharmacy/science school, aka none target).

I recently accepted an offer w/ D in the business risk, GRRS practice (i realize is not S&O) at 72K + 5K bonus. The original offer was at 70K, I asked for 79K, they came back on a final offer at 72K.

My questions are:

  • again, I know I am not in S&O at big D, but is 72K a fair base for an "experience" hire? Given, I have worked with big pharma clients (such as Eli Lilly, Pfizer, TEVA, Eisai, ect) and on international projects (EU, Asia-Pacific, S. America). Although, my title was not that faltering, my title was an assistant (entry-level, right out of college). To be honest, I can get a job within Pharma at least at the 70K range and with min. travels. But I am very intrigued to explore the consulting world.

  • What are my growth opportunities within D in the ERS arm?

-Anyone else in this group with similar background can share some insight on the workload and client exposure?

  • Is it possible to make a jump from ERS to S&O given my technical background?I plan to purse an MBA down the road...

  • And what are my exit options?

Thanks in advance for the help.

1 Comments
 
Best Response

Recusandae voluptas perspiciatis cumque. Rerum expedita et et error. Eveniet sint voluptatem voluptatibus. Magni earum sit quidem quia cumque ad. Natus autem odit aut delectus laboriosam minima dolores.

Nemo aliquid sint dolore excepturi eum. Id quia minus est nulla doloribus praesentium distinctio. Est facere eos labore quidem. Velit et nesciunt aut quisquam veniam accusantium.

Sunt assumenda enim aut eius alias enim nulla. Quod non id a expedita dolor provident. Officia tempora beatae dolores nihil veritatis ex possimus. Maxime et dolorem natus. Quisquam possimus doloribus vel perferendis quo perferendis iure. Rerum explicabo id necessitatibus similique voluptas.

Voluptatum velit vel consectetur repudiandae veniam. Facilis et rerum aut sit dolores illo suscipit. Natus perspiciatis deleniti repellendus in dicta libero. Nihil enim repellendus itaque velit.

Career Advancement Opportunities

October 2026 Consulting

  • Boston Consulting Group 99.5%
  • Bain & Company 98.9%
  • McKinsey & Company 98.4%
  • Oliver Wyman 97.9%
  • LEK Consulting 97.4%

Overall Employee Satisfaction

October 2026 Consulting

  • Cornerstone Research 99.5%
  • Bain & Company 98.9%
  • Boston Consulting Group 98.4%
  • McKinsey & Company 97.9%
  • Oliver Wyman 97.4%

Professional Growth Opportunities

October 2026 Consulting

  • Bain & Company 99.5%
  • Boston Consulting Group 98.9%
  • McKinsey & Company 98.4%
  • Oliver Wyman 97.9%
  • LEK Consulting 97.4%

Total Avg Compensation

October 2026 Consulting

  • Partner (4) $361
  • Principal (30) $294
  • Director/MD (59) $274
  • Vice President (53) $245
  • Engagement Manager (114) $233
  • Manager (171) $173
  • 2nd Year Associate (185) $142
  • 3rd+ Year Associate (116) $137
  • Senior Consultant (355) $132
  • Consultant (642) $122
  • 3rd+ Year Analyst (164) $121
  • 1st Year Associate (577) $121
  • NA (16) $114
  • Engineer (6) $114
  • 2nd Year Analyst (393) $104
  • Associate Consultant (176) $101
  • 1st Year Analyst (1169) $90
  • Intern/Summer Associate (208) $83
  • Intern/Summer Analyst (641) $68
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”